Xenon To Highlight Phase 3 X-TOLE2 Clinical Data And Rational Polytherapy Potential For Azetukalner At EEC 2026

Xenon Pharmaceuticals will showcase Phase 3 X-TOLE2 clinical trial results and discuss polytherapy potential for Azetukalner at EEC 2026 conference.

Why Consumer Health Trends Are Turning Focus To Brain Signals

Exploring why brain signals are becoming central to consumer health monitoring and safety, driven by new technological and market developments.

PLT Health Solutions Brings Its Clinically Supported Branded Ingredient Platform To Vitafoods Asia

PLT Health Solutions introduces its new clinically supported branded ingredient platform at Vitafoods Asia, aiming to enhance product credibility and consumer trust.

Rznomics Joins Lilly Gateway Labs In San Diego To Accelerate RNA Therapeutics

Rznomics joins Lilly Gateway Labs in San Diego to accelerate development of RNA therapeutics, marking a strategic collaboration in biotech innovation.

Orum Therapeutics Announces U.S. FDA Clearance Of An IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate

Orum Therapeutics has received FDA clearance for an IND application for ORM-115, a novel CD123-GSPT1 degrader-antibody conjugate, advancing its clinical pipeline.

Stay Proactive In Dental Care With Daily Gum Line Monitoring

A new approach using daily phone photos for gum health scoring aims to improve early detection of inflammation and prevent dental issues between visits.

The Inner Circle Acknowledges Diane M. Carbo, RN As A Pinnacle Lifetime Member

The Inner Circle has officially acknowledged Diane M. Carbo, RN, as a Pinnacle Lifetime Member, highlighting her longstanding contributions.

Optimizing Spiritual Care Scheduling In Hospitals With Software

Mid-sized hospitals are piloting new software to streamline chaplaincy scheduling and documentation, addressing outdated paper-based processes.

Galibra Neuroscience Receives FDA Orphan Drug And Rare Pediatric Disease Designations For SSADH Deficiency Gene Therapy

Galibra Neuroscience awarded FDA orphan drug and rare pediatric disease designations for its SSADH deficiency gene therapy, advancing its development pipeline.

TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation Of Breaches Of Fiduciary Duties By The Directors And Officers Of TransMedics Group, Inc. – TMDX

Rosen Law Firm announces investigation into possible breaches of fiduciary duties by TransMedics Group directors and officers, prompting legal review.